This review summarizes current research on the mechanisms underlying CDSs, absent in melanoma 2 (AIM2), cyclic GMP-AMP synthase (cGAS), and stimulator of interferon genes (STING)—downstream signaling effectors of cGAS—in the tumor microenvironment. The gene discussed is AIM2; the disease is neoplasm.